Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Consulting agrmnt
Inv. presentation

ARS Pharmaceuticals, Inc. (SBTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/07/2023 4 Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Sold 26,107 shares @ $7.0103, valued at $183k
Sold 18,897 shares @ $7.0631, valued at $133.5k
Exercised 26,017 options to buy @ $1.27, valued at $33k
Exercised 18,897 options to buy @ $1.27, valued at $24k
08/03/2023 4 Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Sold 18,715 shares @ $7.1908, valued at $134.6k
Sold 36,281 shares @ $7.0909, valued at $257.3k
Exercised 18,715 options to buy @ $1.27, valued at $23.8k
Exercised 36,281 options to buy @ $1.27, valued at $46.1k
07/07/2023 4 Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Sold 8,858 shares @ $6.364, valued at $56.4k
Exercised 8,858 options to buy @ $1.27, valued at $11.2k
07/06/2023 4 Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Sold 26,520 shares @ $6.725, valued at $178.3k
Sold 31,112 shares @ $6.414, valued at $199.6k
Sold 33,510 shares @ $6.343, valued at $212.6k
Exercised 26,520 options to buy @ $1.27, valued at $33.7k
Exercised 31,112 options to buy @ $1.27, valued at $39.5k
Exercised 33,510 options to buy @ $1.27, valued at $42.6k
06/28/2023 4 Dadoo Rajeev (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 40,000 options to buy @ $6.5, valued at $260k
06/28/2023 4 RA CAPITAL MANAGEMENT, L.P. (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 40,000 options to buy @ $6.5, valued at $260k
06/28/2023 4 Kelly Michael (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 40,000 options to buy @ $6.5, valued at $260k
06/28/2023 4 Shah Pratik (10% Owner) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 40,000 options to buy @ $6.5, valued at $260k
06/28/2023 4 Thompson Peter A. (10% Owner) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 40,000 options to buy @ $6.5, valued at $260k
06/28/2023 4 Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 40,000 options to buy @ $6.5, valued at $260k
06/28/2023 4 SAUNDERS BRENT L (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 40,000 options to buy @ $6.5, valued at $260k
06/28/2023 4 SCHNEIDER PHILLIP M (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 40,000 options to buy @ $6.5, valued at $260k
06/28/2023 4 Islam Saqib (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 40,000 options to buy @ $6.5, valued at $260k
06/02/2023 4 Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Sold 73,059 shares @ $6.8, valued at $496.8k
Sold 26,941 shares @ $6.95, valued at $187.2k
Exercised 73,059 options to buy @ $1.27, valued at $92.8k
Exercised 26,941 options to buy @ $1.27, valued at $34.2k
05/10/2023 4 Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Sold 43,896 shares @ $4.58, valued at $201k
Sold 57,100 shares @ $6.16, valued at $351.7k
Sold 42,900 shares @ $5.31, valued at $227.8k
Exercised 57,100 options to buy @ $1.27, valued at $72.5k
Exercised 42,900 options to buy @ $1.27, valued at $54.5k
01/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2023 4 Chakma Justin (Chief Business Officer) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 165,000 options to buy @ $8.42, valued at $1.4M
01/05/2023 4 Dorsey Brian (COO) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 145,000 options to buy @ $8.42, valued at $1.2M
01/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2023 4 Lowenthal Richard E (President and CEO) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 1,100,000 options to buy @ $8.42, valued at $9.3M
Granted 350,000 options to buy @ $8.42, valued at $2.9M
12/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/10/2022 4 Chakma Justin (Chief Business Officer) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 236,380 shares @ $0
Granted 236,380 options to buy @ $0.84, valued at $198.6k
Granted 48,260 options to buy @ $0.84, valued at $40.5k
Granted 82,733 options to buy @ $1.44, valued at $119.1k
11/10/2022 4 Shah Pratik (10% Owner) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 10,156,204 shares @ $0
Granted 354,570 options to buy @ $1.44, valued at $510.6k
11/10/2022 4 Karas Eric (Chief Commercial Officer) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 614,588 options to buy @ $1.5, valued at $921.9k
11/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/10/2022 4 Tanimoto Sarina (Chief Medical Officer) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 4,326,854 shares @ $0
Granted 1,772,850 shares @ $0
Granted 1,772,850 shares @ $0
Granted 4,326,854 shares @ $0
Granted 82,733 options to buy @ $0.84, valued at $69.5k
Granted 82,733 options to buy @ $1.44, valued at $119.1k
Granted 236,380 options to buy @ $0.84, valued at $198.6k
Granted 236,380 options to buy @ $1.44, valued at $340.4k
11/10/2022 4 Lowenthal Richard E (President and CEO) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 5,176,822 shares @ $0
Granted 1,772,850 shares @ $0
Granted 4,326,854 shares @ $0
Granted 1,772,850 shares @ $0
Granted 236,380 options to buy @ $0.84, valued at $198.6k
Granted 236,380 options to buy @ $1.44, valued at $340.4k
Granted 82,733 options to buy @ $0.84, valued at $69.5k
Granted 82,733 options to buy @ $1.44, valued at $119.1k
11/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/10/2022 4 Kelly Michael (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 83,225 shares @ $0
Granted 70,422 options to buy @ $0.84, valued at $59.2k
Granted 118,190 options to buy @ $1.44, valued at $170.2k
11/10/2022 4 Dadoo Rajeev (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 3,009,677 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy